
Efficacy and safety of CalliSpheres® drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC study
Author(s) -
Xia Wu,
ShengHua Ying,
Jing Huang,
Changsheng Shi,
Jiansong Ji,
Zhangli Peng,
Gengui Zhou,
Zhichao Sun,
JunHui Sun,
Wenqiang Yu,
Wenhao Hu,
Xin Zhang,
Jian Zhou,
Guoliang Shao,
Zhihai Yu,
Qinming Hou,
Wenjiang Gu,
Tiefeng Li,
Xi Shan Xie,
Guohong Cao,
Haijun Du,
Dedong Zhu,
Haiyun Xu,
Jianda Han,
Wenbin Ji,
Jian Fang,
Ling Li,
Jianbao Zheng,
Jun Luo,
Yu-Tang Chen,
Tie Hu,
Hongjie Hu,
Xiang-Zhao Guo
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.06.44
Subject(s) - medicine , nausea , vomiting , gastroenterology , adverse effect , liver cancer , liver function , response evaluation criteria in solid tumors , prospective cohort study , cancer , complete response , surgery , chemotherapy , phases of clinical research